home page home page|
PubMed list
|
2019
Bersano A, Bedini G, Nava S, Acerbi F, Sebastiano DR, Binelli S, Franceschetti S, Faragò G, Grisoli M, Gioppo A, Ferroli P, Bruzzone MG, Riva D, Ciceri E, Pantaleoni C, Saletti V, Esposito S, Nardocci N, Zibordi F, Caputi L, Marzoli SB, Zedde ML, Pavanello M, Raso A, Capra V, Pantoni L, Sarti C, Pezzini A, Caria F, Dell' Acqua ML, Zini A, Baracchini C, Farina F, Sanguigni S, De Lodovici ML, Bono G, Capone F, Di Lazzaro V, Lanfranconi S, Toscano M, Di Piero V, Sacco S, Carolei A, Toni D, Paciaroni M, Caso V, Perrone P, Calloni MV, Romani A, Cenzato M, Fratianni A, Ciusani E, Prontera P, Lasserve ET, Blecharz K, Vajkoczy P, Parati EA; GEN-O-MA study group (2019) GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease-study protocol and preliminary results. . 40(3): 561-570 (IF 2.) [PubMed] [WebPage] [PDF]
Burek M, König A, Lang M, Fiedler J, Oerter S, Roewer N, Bohnert M, Thal SC, Blecharz-Lang KG, Woitzik J, Thum T, Förster CY (2019) Hypoxia-induced microRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells. Transl. Stroke Res. 10(6): 672-683 (°IF 5.8) [PubMed] [WebPage] [PDF]
Narducci A, Yasuyuki K, Onken J, Blecharz K, Vajkoczy P (2019) In vivo demonstration of blood-brain barrier impairment in Moyamoya disease. Acta Neurochir. (Wien) 161(2): 371-378 (IF 1.8) [PubMed] [WebPage] [PDF]
2018
Blecharz-Lang KG, Prinz V, Burek M, Frey D, Schenkel T, Krug SM, Fromm M, Vajkoczy P (2018) Gelatinolytic activity of autocrine matrix metalloproteinase 9 leads to endothelial de-arrangement in Moyamoya disease. J. Cereb. Blood Flow Metab.
Blecharz-Lang KG, Wagner J, Fries A, Nieminen-Kelhä M, Rösner J, Schneider UC, Vajkoczy P (2018) Interleukin 6-mediated endothelial barrier disturbances can be attenuated by blockade of the IL6 receptor expressed in brain microvascular endothelial cells. Transl. Stroke Res. ###: ###-### (°IF 8.2) [PubMed] [WebPage] [PDF]
2017
Blecharz KG*, Frey D* (*shared first authorship), Schenkel T, Prinz V, Bedini G, Krug SM, Czabanka M, Wagner J, Fromm M, Bersano A, Vajkoczy P (2017) Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J. Cereb. Blood Flow Metab. 37(4): 1527-1539 (IF 6.0) [PubMed] [WebPage] [PDF] [Supplement]
Atangana E, Schneider UC, Blecharz K, Magrini S, Wagner J, Nieminen-Kelhä M, Kremenetskaia I, Heppner FL, Engelhardt B, Vajkoczy P (2017) Intravascular inflammation triggers intracerebral activated microglia and contributes to secondary brain injury after experimental subarachnoid hemorrhage (eSAH). Tansl. Stroke Res. 8(2): 144-156 (IF 8.2) [PubMed] [WebPage] [PDF]
2016
Review
Bedini G, Blecharz KG, Nava S, Vajkoczy P, Alessandri G, Ranieri M, Acerbi F, Ferroli P, Riva D, Esposito S, Pantaleoni C, Nardocci N, Zibordi F, Ciceri E, Parati EA, Bersano A (2016) Vasculogenic and angiogenic pathways in moyamoya disease. Curr. Med. Chem. 23(4): 315-345 (IF 3.2) [PubMed] [WebPage]
2015
Review
Blecharz KG, Colla R, Rohde V, Vajkoczy P (2015) Control of the blood-brain barrier function in cancer cell metastasis. Biol. Cell 107(10): 342-371 (IF 2.6) [PubMed] [WebPage] [PDF]
2014
Protze J, Eichner M, Piontek A, Dinter S, Rossa J, Blecharz KG, Vajkoczy P, Piontek J*, Krause G* (*shared last authorship) (2014) Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5. Cell. Mol. Life Sci. 72(7): 1417-1432 (IF 5.8) [PubMed] [WebPage] [PDF]
Blecharz KG*, Burek M* (*shared first authorship), Bauersachs J, Thum T, Tsikas D, Widder J, Roewer N, Förster CY (2014) Inhibition of proteasome-mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro. Biol. Cell 106(7): 219-235 (IF 3.5) [PubMed] [WebPage] [PDF] [Supplement]
2013
Baumgarten A, Bang C, Tschirner A, Engelmann A, Adams V, von Haehling S, Doehner W, Pregla R, Anker MS, Blecharz K, Meyer R, Hetzer R, Anker SD, Thum T (2013) TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy. Int. J. Cardiol. 168(2): 1447-1452 (IF 5.5) [PubMed] [WebPage] [PDF]
2011
Kleinschnitz C*, Blecharz K* (*shared first authorship), Kahles T, Schwarz T, Kraft P, Göbel K, Meuth SG, Burek M, Thum T, Stoll G, Förster C (2011) Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke 42(4): 1081-1089 (IF 5.7) [PubMed] [WebPage] [PDF] [Supplement]
2010
Blecharz KG, Haghikia A, Stasiolek M, Kruse N, Drenckhahn D, Gold R, Roewer N, Chan A, Förster CY (2010) Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Mult. Scler. 16(3): 293-302 (IF 4.2) [PubMed] [WebPage] [PDF]
2008
Blecharz KG, Drenckhahn D, Förster CY (2008) Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J. Cereb. Blood Flow Metab. 28(6): 1139-1149 (IF 5.7) [PubMed] [WebPage] [PDF]
Theses
Blecharz KG (2010) Molekulare Ziele der Glococorticoidbehandlung unter verschiedenen pathophysiologischen Bedingungen an einem in vitro-Modell der Blut-Hirn-Schranke. Doctoral thesis, Dr. rer. nat., Dept. Anesthesiology, Section Exp. Anesth., Univ. Würzburg, Prof. Carola Förster
Blecharz KG (2005) Wirkung von Glucocorticoiden auf das VE-Cadherin in Hirnendothelzellen der Blut-Hirn-Schranke. Diploma thesis, Biology, Dept. Anatomy & Cell Biol. II, Univ. Würzburg, Prof. Carola Förster